Navigation Links
Calando Pharmaceuticals Publishes Study Showing Anti-Cancer Effect,with Lead RNAi Candidate

gh its internal research and development and also through collaborations and partnerships with pharmaceutical and biotechnology companies.

Calando Technology

Calando's cyclodextrin-containing polymers form the foundation for its two-part siRNA delivery system. The first component is a linear, cyclodextrin-containing polycation that, when mixed with small interfering RNA (siRNA), binds to the anionic "backbone" of the siRNA. The polymer and siRNA self-assemble into nanoparticles of approximately 50-80 nm diameter that fully protect the siRNA from nuclease degradation in serum. The siRNA delivery system has been designed to allow for intravenous injection. Upon delivery to the target cell, the targeting ligand binds to membrane receptors on the cell surface and the RNA-containing nanoparticle is taken into the cell by endocytosis. There, chemistry built into the polymer functions to unpackage the siRNA from the delivery vehicle. In addition to targeting tumors, the targeting of liver cells has also been accomplished in vivo.

About Arrowhead Research Corporation

Arrowhead Research Corporation (www.arrowheadresearch.com) is a publicly-traded nanotechnology company commercializing new technologies in the areas of life sciences, electronics, and energy. Arrowhead is building value for shareholders through the progress of majority owned subsidiaries founded on nanotechnologies originally developed at universities. The company works closely with universities to source early stage deals and to generate rights to intellectual property covering promising new nanotechnologies. Currently, Arrowhead has four subsidiaries commercializing nanotech products and applications, including anti-cancer drugs, RNAi therapeutics, carbon-based electronics and compound semiconductor materials.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995:

This news release contains forward-looking statements within the meaning of th
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Calando Pharmaceuticals Announces Preclinical Efficacy and Safety Data of Targeted, Systemic Delivery of siRNA at AACR Annual Meeting
2. Arrowhead Subsidiaries Insert & Calando Present Data on Cyclosert Drug Delivery System at AACR Meeting
3. Arrowhead Subsidiary Calando Pharmaceuticals Publishes Study Showing Anti-Cancer Effect with Lead RNAi Candidate
4. Arrowhead Subsidiary, Calando Pharmaceuticals Publishes Study on Targeted, Systemic Delivery of siRNA
5. Calando Pharmaceuticals Publishes the First Non-Human Primate Study on Targeted, Systemic Delivery of siRNA in National Academy of Sciences Journal
6. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
7. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
8. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
9. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
10. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
11. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
Post Your Comments:
(Date:7/24/2008)...., July 24 /- Ortho-McNeil Neurologic...als, Inc., announced today,that the U.S. Food and ...clusivity for TOPAMAX(R) (topiramate), based on st...y the FDA to investigate the use of TOPAMAX,in ped...nset seizures., In addition to granting pediatric...
(Date:7/24/2008)...Calif., July 24 /- Alexza,P...day that it has initiated,its second Phase 3 clini...04 is an inhalation product candidate being develo...ts with schizophrenia or bipolar disorder.,Alexza ...pharmacokinetic,(PK) properties resulting from inh...
(Date:7/24/2008)...y 24 /PRNewswire-USNewswire/ -- Headlines claiming...whole story. The small scale,preliminary study th...eproduction, is based on recollected intake of soy...s. "This study is confounded by many,issues, thus ...eal of,caution," warned Dr. Tammy Hedlund, a resea...
(Date:7/24/2008)...hermometer designed to take body temperature, for ...ewswire-FirstCall/ --- Kidz-Med, Inc.,(subsidiary ... ASFX),United States distributor of the Thermofoc...o announce the results of a clinical study,conduct...ty of Milan, in,Milan, Italy, which proves that th...
Breaking Medicine Technology:FDA Grants Pediatric Exclusivity for TOPAMAX(R), Extending the Marketing Exclusivity by Six Months 2FDA Grants Pediatric Exclusivity for TOPAMAX(R), Extending the Marketing Exclusivity by Six Months 3Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 2Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 3Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 4Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 5Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 6Soyfoods Do Not Impact Sperm Count 2Pediatric Study Finds 21st Century Non-Contact Thermometer as Accurate as Conventional Thermometers 2Human embryonic stem cell lines created that avoid immune rejection 8621 1Human embryonic stem cell lines created that avoid immune rejection 8621 2Make Safe Toys Your Holiday Priority 8619 1Make Safe Toys Your Holiday Priority 8619 2Make Safe Toys Your Holiday Priority 8619 3Fisheries should be regarded as a part of the maritime environment 1689 1Fisheries should be regarded as a part of the maritime environment 1689 2It is important to demonstrate the influence of the microenvironment in the process of metastasis 1687 1It is important to demonstrate the influence of the microenvironment in the process of metastasis 1687 2It is important to demonstrate the influence of the microenvironment in the process of metastasis 1687 3
...f.--(BUSINESS WIRE)--Jun 4, 2007 - Researchers at ...luminated the path,taken by human neural stem cell...nd mice, and found that the cells successfully,nav...h group placed miniscule particles of iron inside,...magnetic,resonance imaging. With the ability to mo...
... Affiliated Physicians Participate in ASCO,Proceed...ding cancer,researcher affiliated with the US Onco...ndomized, multicenter phase III trial,that compare...o,regimens of adjuvant therapy for patients with h...iven in an oral presentation by Dr.,David Loesch o...
Other Medicine Technology:Stanford Researchers Track Human Stem Cells Transplanted Into Rat,Brain 2Stanford Researchers Track Human Stem Cells Transplanted Into Rat,Brain 3Stanford Researchers Track Human Stem Cells Transplanted Into Rat,Brain 4New Study Shows Doxorubicin Plus Paclitaxel Followed by Weekly,Paclitaxel as Adjuvant Therapy for High Risk Breast Cancer,Warranted in Place of Doxorubicin Plus Cyclophosphamide Followed by,Paclitaxel 2New Study Shows Doxorubicin Plus Paclitaxel Followed by Weekly,Paclitaxel as Adjuvant Therapy for High Risk Breast Cancer,Warranted in Place of Doxorubicin Plus Cyclophosphamide Followed by,Paclitaxel 3New Study Shows Doxorubicin Plus Paclitaxel Followed by Weekly,Paclitaxel as Adjuvant Therapy for High Risk Breast Cancer,Warranted in Place of Doxorubicin Plus Cyclophosphamide Followed by,Paclitaxel 4New Study Shows Doxorubicin Plus Paclitaxel Followed by Weekly,Paclitaxel as Adjuvant Therapy for High Risk Breast Cancer,Warranted in Place of Doxorubicin Plus Cyclophosphamide Followed by,Paclitaxel 5
(Date:7/25/2008)...CESS, N.Y., July 25 /PRNewswire-USNewswire/ -- Ant...f Quality Officer and Vice President,of Strategic ...th Fund, a,national foundation committed to improv...ted the foundation,s Program on Health Care Qualit....newscom.com/cgi-bin/prnh/20080725/DC28791LOGO ),...
(Date:7/25/2008)...ON, Calif., July 25 /PRNewswire-FirstCall/ -- Thor...n device-based mechanical,circulatory support ther...,today announced that it will report its operating...hs of fiscal 2008 on Thursday, July 31., The comp...ancial,results and operating activities to all int...
(Date:7/25/2008)...A July 24, 2008 Being overweight or obese is not...ut is also a public health issue that impacts othe...ealth Services Research reveals that the extra Me...ple could place a significant financial burden on ...dollars across the entire current Medicare populat...
(Date:7/25/2008)...July 25 /PRNewswire/ -- BeaconEquity.com announces... news today., Investors can view all of the daily...nEquity.com/m , Today,s Trade Alerts include: DUS...ok Pharmaceuticals Inc. (Nasdaq: MBRK ), NovaMed ..., Affymetrix Inc. (Nasdaq: AFFX ) and,Abaxis Inc....
Breaking Medicine News(10 mins):Health News:IPRO Welcomes Back Anthony Shih as Chief Quality Officer, Strategic Planning Lead 2Health News:Thoratec Schedules Second Quarter 2008 Conference Call, Webcast 2Health News:BeaconEquity.com Issues Technical Trade Alerts on Healthcare/Pharmaceutical Stocks: DUSA, MBRK, NOVA, ADLR, AFFX, ABAX 2Health News:BeaconEquity.com Issues Technical Trade Alerts on Healthcare/Pharmaceutical Stocks: DUSA, MBRK, NOVA, ADLR, AFFX, ABAX 3
...n have Complication as its other name. Among the m...dreaded would be the foot ulcer, as damage can be ... with this dreaded foot ulcer, a boon in disguise ...gh voltage electric current to the skin. //Such an...
...s can also repair damaged ankles claim the researc...ing knee injuries, but it is also a valuable metho...sive surgical technique it is being applied in new... relieve different ankle problems, including ligam...
...ped on a daily basis. One of these latest laser te...ering from a degenerative eye condition. This dege...erneath the retina and leak fluid, causing scarrin...ve come up with a new therapy called the Photodyna...
... reducer Paracetamol, whose active ingredient is A...f the stroke. The fever-reducer acetaminophen lowe...e, according to a new study conducted in The Nethe...ing the first few days, though small enough that t...
Other Medicine News:Health News:Arthroscopy for Ankles 2
Eftiar® offers the vitreoretinal surgeon a temporary tamponade for efficient re-attachment of the retina, release of subretinal fluid, dissection of fibro-vascular proliferation and controlling r
ROB-NEL Catheters (100% Latex-Free)
Red Rubber Robinson Catheters (Latex)
Urethral Red Rubber Catheters (Latex)
Medicine Products: